AU1590788A - Leukaemia-inhibitory factor - Google Patents

Leukaemia-inhibitory factor

Info

Publication number
AU1590788A
AU1590788A AU15907/88A AU1590788A AU1590788A AU 1590788 A AU1590788 A AU 1590788A AU 15907/88 A AU15907/88 A AU 15907/88A AU 1590788 A AU1590788 A AU 1590788A AU 1590788 A AU1590788 A AU 1590788A
Authority
AU
Australia
Prior art keywords
leukaemia
inhibitory factor
inhibitory
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU15907/88A
Other versions
AU609128B2 (en
Inventor
David Paul Gearing
Nicholas Martin Gough
Douglas James Hilton
Julie Ann King
Donald Metcalf
Edouard Collins Nice
Nicos Anthony Nicola
Richard John Simpson
Tracy Ann Willson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL IP Investments Pty Ltd
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Priority to AU15907/88A priority Critical patent/AU609128B2/en
Publication of AU1590788A publication Critical patent/AU1590788A/en
Application granted granted Critical
Publication of AU609128B2 publication Critical patent/AU609128B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU15907/88A 1987-04-02 1988-03-31 Leukaemia-inhibitory factor Expired AU609128B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU15907/88A AU609128B2 (en) 1987-04-02 1988-03-31 Leukaemia-inhibitory factor

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPI1209 1987-04-02
AUPI120987 1987-04-02
AUPI3317 1987-07-24
AUPI4903 1987-10-15
AUPI6005 1987-12-21
AU15907/88A AU609128B2 (en) 1987-04-02 1988-03-31 Leukaemia-inhibitory factor

Publications (2)

Publication Number Publication Date
AU1590788A true AU1590788A (en) 1988-11-02
AU609128B2 AU609128B2 (en) 1991-04-26

Family

ID=25616187

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15907/88A Expired AU609128B2 (en) 1987-04-02 1988-03-31 Leukaemia-inhibitory factor

Country Status (1)

Country Link
AU (1) AU609128B2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008188A1 (en) * 1989-01-10 1990-07-26 Amrad Corporation Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1990010454A1 (en) * 1989-03-07 1990-09-20 Amrad Corporation Limited Metabolic effects of leukaemia inhibitory factor on bone
WO1991007992A1 (en) * 1989-11-24 1991-06-13 Monash University Proliferative action of leukaemia inhibitory factor on satellite cells
WO1991008752A1 (en) * 1989-12-18 1991-06-27 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
WO1991014443A1 (en) * 1990-03-20 1991-10-03 Amrad Corporation Limited A method for regulating neuron development and maintenance
AU623987B2 (en) * 1989-03-07 1992-05-28 Amrad Operations Pty. Limited Metabolic effects of leukaemia inhibitory factor on bone
WO1993012806A1 (en) * 1991-12-24 1993-07-08 Amrad Corporation Limited A method for the treatment of tumours and sarcomas
WO1999027950A1 (en) * 1997-11-26 1999-06-10 Amrad Operations Pty. Ltd. Compositions of leukaemia inhibitory factor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622515B2 (en) * 1989-01-10 1992-04-09 Amrad Operations Pty. Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3545568A1 (en) * 1985-12-21 1987-07-16 Hoechst Ag GM-CSF-PROTEIN, ITS DERIVATIVES, PRODUCTION OF SUCH PROTEINS AND THEIR USE
CA1320906C (en) * 1986-06-04 1993-08-03 Daniel R. Twardzik Interleukin-2 induced antineoplastic peptide
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008188A1 (en) * 1989-01-10 1990-07-26 Amrad Corporation Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
WO1990010454A1 (en) * 1989-03-07 1990-09-20 Amrad Corporation Limited Metabolic effects of leukaemia inhibitory factor on bone
AU623987B2 (en) * 1989-03-07 1992-05-28 Amrad Operations Pty. Limited Metabolic effects of leukaemia inhibitory factor on bone
WO1991007992A1 (en) * 1989-11-24 1991-06-13 Monash University Proliferative action of leukaemia inhibitory factor on satellite cells
AU624284B2 (en) * 1989-11-24 1992-06-04 Monash University Proliferative action of leukaemia inhibitory factor on satellite cells
WO1991008752A1 (en) * 1989-12-18 1991-06-27 Amrad Corporation Limited Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
WO1991014443A1 (en) * 1990-03-20 1991-10-03 Amrad Corporation Limited A method for regulating neuron development and maintenance
WO1993012806A1 (en) * 1991-12-24 1993-07-08 Amrad Corporation Limited A method for the treatment of tumours and sarcomas
WO1999027950A1 (en) * 1997-11-26 1999-06-10 Amrad Operations Pty. Ltd. Compositions of leukaemia inhibitory factor

Also Published As

Publication number Publication date
AU609128B2 (en) 1991-04-26

Similar Documents

Publication Publication Date Title
AU614965B2 (en) Thiadiazinones
AU583762B2 (en) Piperazinyl-heterocyclic compounds
AU2611588A (en) New phenylethanolamines
AU5578390A (en) Dioxothiazolidine derivatives
AU1741788A (en) Azolylmethyl-cyclopropyl derivatives
AU1407388A (en) Substituted di-t-butylphenols
AU2222388A (en) Peptidylheterocycles
AU1381888A (en) Timeswitches
AU1301788A (en) Chemo-radio-immuno-conjugates
AU2142288A (en) New aluminium-magnesium-hydroxy-compounds
AU1764488A (en) Substituted 5-methylamino-1-arylpyrazoles
AU2055488A (en) 7-Acylaminocephalosporin derivatives
AU1210388A (en) Novel aminohydrocarbyl-substituted ketoximosilanes
AU2150088A (en) Isoxazole-beta-carboline derivatives
AU2665388A (en) 17-methylene-and 17-ethylidene-estratrienes
AU1590788A (en) Leukaemia-inhibitory factor
AU2142888A (en) Novel complex
AU1862088A (en) Hydroxyethyl-Azolyl derivatives
AU1158888A (en) Scraper-spreader
AU578867B1 (en) Tack-off assembly
AU1366388A (en) Videosystem
AU1390588A (en) Store
AU2021888A (en) Sulphonylaminoguanidinoazines
AU2698888A (en) Naphthothiazepinones
AU2505988A (en) 3-aminopyrazolin-5-ones